Skip to Main Content
Newsroom
Get in Touch
LinkedIn
Editas Medicine Linkedin
Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors
Newsroom
Get in Touch
LinkedIn
Purchasing Policy Terms and Conditions
+
-
Editas Newsroom
Jan
20
Editas Medicine Announces Pricing of Offering of Common Stock
Jan
19
Editas Medicine Announces Offering of Common Stock
Jan
11
Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference